Olaplex (OLPX) Financials

$1.28 -0.02 (-1.54%)

Closing price 10/2/2025 04:00 PM Eastern

Extended Trading

$1.30 +0.02 (+1.56%)

As of 10/2/2025 04:46 PM Eastern

Annual Income Statements for Olaplex

This table shows Olaplex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	39	221	244	62	20
Consolidated Net Income / (Loss)	39	221	244	62	20
Net Income / (Loss) Continuing Operations	39	221	244	62	20
Total Pre-Tax Income	47	276	305	77	27
Total Operating Income	86	334	364	108	67
Total Gross Profit	180	474	520	319	292
Total Revenue	282	598	704	458	423
Operating Revenue	282	598	704	458	423
Total Cost of Revenue	103	125	185	140	130
Operating Cost of Revenue	103	125	185	140	130
Total Operating Expenses	93	140	155	210	225
Selling, General & Admin Expense	37	99	114	169	182
Amortization Expense	40	41	41	41	44
Total Other Income / (Expense), net	-39	-59	-59	-32	-40
Interest Expense	39	61	63	58	60
Interest & Investment Income	-	0.00	2.78	19	25
Other Income / (Expense), net	-0.19	2.60	0.83	7.62	-5.82
Income Tax Expense	7.98	55	61	15	7.39
Basic Earnings per Share	$0.06	$0.34	$0.38	$0.09	$0.03
Weighted Average Basic Shares Outstanding	635.39M	648.17M	649.09M	654.59M	661.98M
Diluted Earnings per Share	$0.06	$0.32	$0.35	$0.09	$0.03
Weighted Average Diluted Shares Outstanding	636.82M	689.92M	691.01M	677.58M	665.40M
Weighted Average Basic & Diluted Shares Outstanding	-	648.79M	651.90M	660.76M	664.62M

This table shows Olaplex's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	61	34	21	6.16	20	14	7.75	5.78	15	-8.80	0.47
Consolidated Net Income / (Loss)	61	34	21	6.16	20	14	7.75	5.78	15	-8.80	0.47
Net Income / (Loss) Continuing Operations	61	34	21	6.16	20	14	7.75	5.78	15	-8.80	0.47
Total Pre-Tax Income	76	41	25	7.95	26	17	10	7.68	20	-11	0.88
Total Operating Income	89	47	36	19	37	17	20	16	28	3.05	8.48
Total Gross Profit	130	92	81	77	84	77	71	72	82	67	67
Total Revenue	176	131	114	109	124	112	99	104	119	101	97
Operating Revenue	176	131	114	109	124	112	99	104	119	101	97
Total Cost of Revenue	47	39	33	32	40	35	28	32	37	34	30
Operating Cost of Revenue	47	39	33	32	40	35	28	32	37	34	30
Total Operating Expenses	41	45	45	59	47	60	52	56	54	64	59
Selling, General & Admin Expense	31	35	35	48	36	49	40	45	43	53	48
Amortization Expense	10	10	10	10	10	10	11	11	11	11	11
Total Other Income / (Expense), net	-13	-5.85	-10	-11	-10	0.09	-9.25	-8.60	-8.34	-14	-7.60
Interest Expense	10	13	14	15	15	15	15	15	16	15	14
Interest & Investment Income	-	-	3.38	4.47	5.18	5.80	6.20	6.26	6.61	6.31	5.95
Other Income / (Expense), net	-2.25	4.68	0.24	-0.60	-0.97	8.95	-0.95	-0.26	0.67	-5.28	0.18
Income Tax Expense	15	7.58	4.30	1.80	5.89	3.15	2.62	1.90	4.86	-2.00	0.42
Basic Earnings per Share	$0.09	$0.05	$0.03	$0.01	$0.03	$0.02	$0.01	$0.01	$0.02	($0.01)	$0.00
Weighted Average Basic Shares Outstanding	649.10M	649.09M	651.73M	654.35M	654.70M	654.59M	660.82M	661.73M	662.25M	661.98M	664.69M
Diluted Earnings per Share	$0.09	$0.04	$0.03	$0.01	$0.03	$0.02	$0.01	$0.01	$0.02	($0.01)	$0.00
Weighted Average Diluted Shares Outstanding	691.26M	691.01M	683.49M	680.35M	678.76M	677.58M	663.57M	663.55M	666.15M	665.40M	666.46M
Weighted Average Basic & Diluted Shares Outstanding	649.18M	651.90M	654.28M	654.70M	654.73M	660.76M	661.76M	661.98M	662.92M	664.62M	665.92M

This table details how cash moves in and out of Olaplex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	11	175	136	144	120
Net Cash From Operating Activities	129	200	255	178	143
Net Cash From Continuing Operating Activities	129	200	255	178	143
Net Income / (Loss) Continuing Operations	39	221	244	62	20
Consolidated Net Income / (Loss)	39	221	244	62	20
Depreciation Expense	0.00	0.16	0.36	0.48	0.49
Amortization Expense	92	52	50	52	55
Non-Cash Adjustments To Reconcile Net Income	1.53	3.96	35	25	22
Changes in Operating Assets and Liabilities, net	-4.18	-76	-74	38	46
Net Cash From Investing Activities	-1,382	-6.27	-2.68	-3.61	-4.89
Net Cash From Continuing Investing Activities	-1,382	-6.27	-2.68	-3.61	-4.89
Purchase of Property, Plant & Equipment	-0.03	-0.88	-0.65	-0.38	-1.12
Acquisitions	-1,382	-0.89	-2.03	-3.24	-3.77
Net Cash From Financing Activities	1,264	-18	-116	-30	-19
Net Cash From Continuing Financing Activities	1,264	-18	-116	-30	-19
Repayment of Debt	-76	-20	-792	-8.44	-6.75
Issuance of Debt	850	0.00	675	0.00	0.00
Other Financing Activities, net	0.00	1.14	1.10	-22	-12
Cash Interest Paid	35	58	41	60	60
Cash Income Taxes Paid	9.91	34	60	7.74	12

This table details how cash moves in and out of Olaplex's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	51	73	47	9.08	51	37	41	0.42	31	47	-5.07
Net Cash From Operating Activities	54	74	48	27	53	49	44	16	33	50	-2.92
Net Cash From Continuing Operating Activities	54	74	48	27	53	49	44	16	33	50	-2.92
Net Income / (Loss) Continuing Operations	61	34	21	6.16	20	14	7.75	5.78	15	-8.80	0.47
Consolidated Net Income / (Loss)	61	34	21	6.16	20	14	7.75	5.78	15	-8.80	0.47
Depreciation Expense	0.08	0.13	0.12	0.11	0.11	0.14	0.15	0.14	0.11	0.09	0.09
Amortization Expense	14	11	13	13	13	13	14	13	14	14	14
Non-Cash Adjustments To Reconcile Net Income	3.81	4.31	4.89	6.46	6.59	7.43	4.31	4.88	4.10	9.20	4.29
Changes in Operating Assets and Liabilities, net	-25	24	9.60	1.53	13	14	18	-8.04	0.65	36	-21
Net Cash From Investing Activities	-0.77	-0.97	-0.63	-1.37	-0.91	-0.71	-1.08	-1.09	-1.19	-1.52	-1.00
Net Cash From Continuing Investing Activities	-0.77	-0.97	-0.63	-1.37	-0.91	-0.71	-1.08	-1.09	-1.19	-1.52	-1.00
Purchase of Property, Plant & Equipment	-0.03	-0.55	-0.11	-0.02	-0.11	-0.14	-0.45	-0.11	-0.13	-0.43	-0.05
Acquisitions	-0.74	-0.42	-0.52	-1.34	-0.80	-0.58	-0.63	-0.99	-1.06	-1.09	-0.95
Net Cash From Financing Activities	-1.62	0.86	-0.93	-17	-1.34	-12	-1.52	-15	-1.37	-1.00	-1.16
Net Cash From Continuing Financing Activities	-1.62	0.86	-0.93	-17	-1.34	-12	-1.52	-15	-1.37	-1.00	-1.16
Repayment of Debt	-1.69	0.00	-3.38	-1.69	-1.69	-1.69	-1.69	-1.69	-1.69	-1.69	-1.69
Other Financing Activities, net	0.07	0.86	2.45	-15	0.35	-9.82	0.17	-13	0.32	0.69	0.53
Cash Interest Paid	8.23	20	14	15	15	15	15	10	21	14	13
Cash Income Taxes Paid	20	5.02	0.09	9.42	0.02	-1.79	5.00	5.56	2.08	-0.26	0.62

This table presents Olaplex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	1,333	1,560	1,698	1,740	1,768
Total Current Assets	61	335	522	613	690
Cash & Equivalents	11	186	323	466	586
Accounts Receivable	14	41	46	41	15
Inventories, net	34	98	144	96	75
Prepaid Expenses	-	-	-	9.95	14
Plant, Property, & Equipment, net	0.03	0.75	1.03	0.93	1.44
Total Noncurrent Assets	1,271	1,224	1,174	1,126	1,077
Goodwill	168	168	168	168	168
Intangible Assets	1,092	1,043	995	948	900
Other Noncurrent Operating Assets	-	4.50	11	10	8.72
Total Liabilities & Shareholders' Equity	1,333	1,560	1,698	1,740	1,768
Total Liabilities	802	1,036	917	895	893
Total Current Liabilities	47	73	55	56	65
Short-Term Debt	20	20	8.44	6.75	6.75
Accounts Payable	17	23	9.75	7.07	10
Accrued Expenses	9.86	17	17	30	36
Current Deferred & Payable Income Tax Liabilities	-	12	3.42	13	12
Total Noncurrent Liabilities	755	963	862	839	829
Long-Term Debt	755	738	654	649	644
Noncurrent Deferred & Payable Income Tax Liabilities	-	0.00	1.62	3.02	5.16
Other Noncurrent Operating Liabilities	-	-	206	187	180
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	531	524	781	845	874
Total Preferred & Common Equity	531	524	781	845	874
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	531	524	781	845	874
Common Stock	531	304	314	317	329
Retained Earnings	0.00	221	465	526	546
Accumulated Other Comprehensive Income / (Loss)	-	0.00	2.58	1.37	-0.77

This table presents Olaplex's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2022	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	6/30/2022	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	1,632	1,697	1,726	1,723	1,742	1,753	1,757	1,759	1,771
Total Current Assets	425	497	564	571	601	639	654	670	704
Cash & Equivalents	198	249	369	378	430	508	508	539	581
Accounts Receivable	81	93	46	50	52	26	34	35	24
Inventories, net	140	151	132	129	113	95	100	86	79
Prepaid Expenses	-	-	-	-	-	-	-	-	20
Plant, Property, & Equipment, net	0.67	0.61	1.03	0.93	0.93	1.24	1.23	1.24	1.48
Total Noncurrent Assets	1,206	1,199	1,161	1,151	1,141	1,113	1,101	1,088	1,066
Goodwill	168	168	168	168	168	168	168	168	168
Intangible Assets	1,019	1,007	983	972	960	936	923	911	887
Other Noncurrent Operating Assets	6.23	10	10	11	12	8.42	9.37	8.43	10
Total Liabilities & Shareholders' Equity	1,632	1,697	1,726	1,723	1,742	1,753	1,757	1,759	1,771
Total Liabilities	952	953	919	905	902	898	893	879	893
Total Current Liabilities	87	89	58	61	56	60	71	57	66
Short-Term Debt	6.75	6.75	6.75	6.75	6.75	6.75	6.75	6.75	6.75
Accounts Payable	41	40	26	14	13	17	23	11	24
Accrued Expenses	21	26	20	25	17	18	23	20	23
Current Deferred & Payable Income Tax Liabilities	18	16	5.80	16	2.50	4.92	5.34	5.65	12
Total Noncurrent Liabilities	865	864	861	844	846	838	823	823	827
Long-Term Debt	657	656	653	652	650	648	646	645	642
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	2.30	2.75	4.07	2.68	2.14	3.64	5.07
Other Noncurrent Operating Liabilities	-	-	-	189	191	188	174	174	180
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	679	744	807	818	840	856	863	880	878
Total Preferred & Common Equity	679	744	807	818	840	856	863	880	878
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	679	744	807	818	840	856	863	880	878
Common Stock	309	311	319	322	325	321	323	326	333
Retained Earnings	370	431	486	492	512	534	540	555	546
Accumulated Other Comprehensive Income / (Loss)	-	1.93	2.02	3.67	2.81	1.00	-0.08	-0.99	-0.75

This table displays calculated financial ratios and metrics derived from Olaplex's official financial filings.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-
Revenue Growth	0.00%	112.00%	17.70%	-34.93%	-7.77%
EBITDA Growth	0.00%	117.96%	7.05%	-59.62%	-30.68%
EBIT Growth	0.00%	292.02%	8.45%	-68.28%	-47.24%
NOPAT Growth	0.00%	274.09%	8.85%	-70.18%	-44.11%
Net Income Growth	0.00%	462.11%	10.55%	-74.77%	-68.30%
EPS Growth	0.00%	433.33%	9.38%	-74.29%	-66.67%
Operating Cash Flow Growth	0.00%	55.09%	27.64%	-30.47%	-19.41%
Free Cash Flow Firm Growth	0.00%	0.00%	103.48%	-64.72%	-16.98%
Invested Capital Growth	0.00%	2.01%	-15.16%	-7.72%	-9.23%
Revenue Q/Q Growth	0.00%	0.00%	-4.83%	-3.98%	-2.53%
EBITDA Q/Q Growth	0.00%	0.00%	-10.89%	-12.53%	-19.24%
EBIT Q/Q Growth	0.00%	0.00%	-11.98%	-18.11%	-31.69%
NOPAT Q/Q Growth	0.00%	0.00%	-12.23%	-21.93%	-22.40%
Net Income Q/Q Growth	0.00%	0.00%	-12.75%	-24.08%	-53.98%
EPS Q/Q Growth	0.00%	0.00%	-12.50%	-18.18%	-50.00%
Operating Cash Flow Q/Q Growth	0.00%	14.44%	1.52%	-12.12%	0.44%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-57.59%	4.51%
Invested Capital Q/Q Growth	0.00%	0.00%	-17.92%	-3.14%	-5.42%
Profitability Metrics	-	-	-	-	-
Gross Margin	63.63%	79.19%	73.77%	69.52%	69.15%
EBITDA Margin	63.15%	64.93%	59.06%	36.65%	27.55%
Operating Margin	30.50%	55.84%	51.74%	23.61%	15.84%
EBIT Margin	30.44%	56.28%	51.86%	25.28%	14.46%
Profit (Net Income) Margin	13.92%	36.90%	34.66%	13.44%	4.62%
Tax Burden Percent	83.11%	80.11%	79.96%	80.28%	72.54%
Interest Burden Percent	55.01%	81.84%	83.58%	66.23%	44.03%
Effective Tax Rate	16.89%	19.89%	20.04%	19.73%	27.46%
Return on Invested Capital (ROIC)	5.52%	20.46%	23.86%	8.06%	4.92%
ROIC Less NNEP Spread (ROIC-NNEP)	1.30%	14.45%	15.54%	-1.49%	-17.95%
Return on Net Nonoperating Assets (RNNOA)	1.88%	21.39%	13.54%	-0.49%	-2.65%
Return on Equity (ROE)	7.40%	41.86%	37.40%	7.58%	2.27%
Cash Return on Invested Capital (CROIC)	0.00%	18.47%	40.27%	16.10%	14.60%
Operating Return on Assets (OROA)	6.45%	23.28%	22.42%	6.74%	3.48%
Return on Assets (ROA)	2.95%	15.26%	14.98%	3.58%	1.11%
Return on Common Equity (ROCE)	7.40%	41.86%	37.40%	7.58%	2.27%
Return on Equity Simple (ROE_SIMPLE)	7.40%	42.11%	31.25%	7.29%	2.23%
Net Operating Profit after Tax (NOPAT)	72	268	291	87	49
NOPAT Margin	25.35%	44.74%	41.37%	18.96%	11.49%
Net Nonoperating Expense Percent (NNEP)	4.22%	6.01%	8.32%	9.55%	22.87%
Return On Investment Capital (ROIC_SIMPLE)	-	-	20.18%	5.79%	3.18%
Cost of Revenue to Revenue	36.37%	20.81%	26.23%	30.48%	30.85%
SG&A Expenses to Revenue	13.17%	16.52%	16.17%	36.86%	42.99%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	33.12%	23.34%	22.03%	45.91%	53.32%
Earnings before Interest and Taxes (EBIT)	86	337	365	116	61
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	178	389	416	168	116
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	2.92	36.01	4.33	1.97	1.31
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	5.48	31.55	4.80	3.63	2.71
Price to Earnings (P/E)	39.40	85.51	13.86	27.00	58.75
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.54%	1.17%	7.22%	3.70%	1.70%
Enterprise Value to Invested Capital (EV/IC)	1.79	14.72	3.32	1.79	1.29
Enterprise Value to Revenue (EV/Rev)	8.19	32.51	5.29	4.04	2.87
Enterprise Value to EBITDA (EV/EBITDA)	12.97	50.07	8.95	11.03	10.40
Enterprise Value to EBIT (EV/EBIT)	26.92	57.76	10.19	15.99	19.82
Enterprise Value to NOPAT (EV/NOPAT)	32.31	72.67	12.77	21.32	24.95
Enterprise Value to Operating Cash Flow (EV/OCF)	17.93	97.24	14.58	10.43	8.47
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	80.50	7.57	10.68	8.41
Leverage & Solvency	-	-	-	-	-
Debt to Equity	1.46	1.45	0.85	0.78	0.74
Long-Term Debt to Equity	1.42	1.41	0.84	0.77	0.74
Financial Leverage	1.44	1.48	0.87	0.33	0.15
Leverage Ratio	2.51	2.74	2.50	2.11	2.04
Compound Leverage Factor	1.38	2.24	2.09	1.40	0.90
Debt to Total Capital	59.37%	59.12%	45.91%	43.70%	42.66%
Short-Term Debt to Total Capital	1.54%	1.57%	0.58%	0.45%	0.44%
Long-Term Debt to Total Capital	57.83%	57.55%	45.32%	43.25%	42.21%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	40.63%	40.88%	54.09%	56.30%	57.34%
Debt to EBITDA	4.35	1.95	1.59	3.90	5.59
Net Debt to EBITDA	4.29	1.47	0.82	1.13	0.55
Long-Term Debt to EBITDA	4.24	1.90	1.57	3.86	5.53
Debt to NOPAT	10.84	2.83	2.27	7.55	13.40
Net Debt to NOPAT	10.68	2.14	1.17	2.18	1.33
Long-Term Debt to NOPAT	10.56	2.76	2.25	7.47	13.26
Altman Z-Score	1.60	12.43	4.05	2.41	1.98
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	1.31	4.60	9.48	10.92	10.67
Quick Ratio	0.54	3.12	6.70	9.04	9.29
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	242	492	173	144
Operating Cash Flow to CapEx	477,685.19%	22,860.46%	39,280.62%	47,341.87%	12,728.47%
Free Cash Flow to Firm to Interest Expense	0.00	3.95	7.83	2.99	2.42
Operating Cash Flow to Interest Expense	3.34	3.27	4.07	3.06	2.40
Operating Cash Flow Less CapEx to Interest Expense	3.34	3.26	4.06	3.06	2.38
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.21	0.41	0.43	0.27	0.24
Accounts Receivable Turnover	19.63	21.70	16.19	10.52	15.13
Inventory Turnover	3.06	1.89	1.52	1.16	1.52
Fixed Asset Turnover	8,301.47	1,532.30	790.87	466.70	356.38
Accounts Payable Turnover	6.11	6.21	11.17	16.61	14.90
Days Sales Outstanding (DSO)	18.59	16.82	22.54	34.70	24.12
Days Inventory Outstanding (DIO)	119.44	193.42	239.90	314.05	239.48
Days Payable Outstanding (DPO)	59.78	58.82	32.67	21.98	24.49
Cash Conversion Cycle (CCC)	78.25	151.42	229.77	326.78	239.11
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	1,295	1,321	1,121	1,034	939
Invested Capital Turnover	0.22	0.46	0.58	0.43	0.43
Increase / (Decrease) in Invested Capital	0.00	26	-200	-87	-95
Enterprise Value (EV)	2,312	19,452	3,722	1,852	1,211
Market Capitalization	1,548	18,880	3,382	1,663	1,147
Book Value per Share	$0.84	$0.81	$1.20	$1.29	$1.32
Tangible Book Value per Share	($1.15)	($1.06)	($0.59)	($0.41)	($0.29)
Total Capital	1,306	1,283	1,444	1,501	1,525
Total Debt	775	758	663	656	650
Total Long-Term Debt	755	738	654	649	644
Net Debt	765	572	340	189	64
Capital Expenditures (CapEx)	0.03	0.88	0.65	0.38	1.12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	24	96	153	97	46
Debt-free Net Working Capital (DFNWC)	35	282	476	564	632
Net Working Capital (NWC)	15	262	467	557	625
Net Nonoperating Expense (NNE)	32	47	47	25	29
Net Nonoperating Obligations (NNO)	765	797	340	189	64
Total Depreciation and Amortization (D&A)	92	52	51	52	55
Debt-free, Cash-free Net Working Capital to Revenue	8.40%	16.04%	21.69%	21.25%	10.85%
Debt-free Net Working Capital to Revenue	12.29%	47.19%	67.53%	123.02%	149.48%
Net Working Capital to Revenue	5.16%	43.83%	66.33%	121.55%	147.88%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.38	$0.09	$0.03
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	649.09M	654.59M	661.98M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.35	$0.09	$0.03
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	691.01M	677.58M	665.40M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	651.90M	660.76M	664.62M
Normalized Net Operating Profit after Tax (NOPAT)	85	268	291	87	49
Normalized NOPAT Margin	30.21%	44.74%	41.37%	18.96%	11.49%
Pre Tax Income Margin	16.74%	46.06%	43.34%	16.74%	6.37%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	2.22	5.51	5.82	2.00	1.03
NOPAT to Interest Expense	1.85	4.38	4.64	1.50	0.81
EBIT Less CapEx to Interest Expense	2.22	5.49	5.81	1.99	1.01
NOPAT Less CapEx to Interest Expense	1.85	4.36	4.63	1.49	0.80
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	1,196.60%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	1,196.60%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Olaplex's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.18%	-21.49%	-38.89%	-48.20%	-29.98%	-14.54%	-13.08%	-4.85%	-3.62%	-9.82%	-1.95%
EBITDA Growth	0.83%	-44.56%	-59.80%	-76.48%	-50.85%	-38.04%	-32.39%	-4.43%	-13.65%	-70.75%	-31.36%
EBIT Growth	-0.45%	-49.00%	-66.92%	-84.71%	-58.62%	-49.52%	-47.86%	-11.81%	-19.85%	-108.55%	-53.65%
NOPAT Growth	3.50%	-51.39%	-65.80%	-84.81%	-59.85%	-63.46%	-50.34%	-15.63%	-26.06%	-84.81%	-69.47%
Net Income Growth	7.37%	-51.48%	-66.17%	-92.98%	-66.48%	-58.07%	-63.05%	-6.12%	-27.34%	-162.41%	-94.00%
EPS Growth	12.50%	-55.56%	-66.67%	-92.31%	-66.67%	-50.00%	-66.67%	0.00%	-33.33%	-150.00%	-100.00%
Operating Cash Flow Growth	-2.92%	5.47%	-33.18%	-51.86%	-0.64%	-33.30%	-9.11%	-39.84%	-37.35%	1.27%	-106.67%
Free Cash Flow Firm Growth	102.22%	0.00%	105.01%	121.47%	1,074.33%	-57.85%	402.26%	-62.38%	-70.48%	-3.02%	-80.76%
Invested Capital Growth	3.27%	-15.16%	-2.48%	-18.88%	-21.80%	-7.72%	-23.03%	-8.14%	-7.04%	-9.23%	-5.59%
Revenue Q/Q Growth	-16.33%	-25.92%	-12.95%	-4.00%	13.10%	-9.58%	-11.47%	5.09%	14.56%	-15.40%	-3.74%
EBITDA Q/Q Growth	-23.92%	-36.94%	-23.42%	-35.97%	58.97%	-20.51%	-16.44%	-9.49%	43.64%	-73.07%	96.08%
EBIT Q/Q Growth	-27.24%	-40.15%	-30.79%	-49.28%	96.97%	-26.99%	-28.51%	-14.23%	79.01%	-107.79%	487.72%
NOPAT Q/Q Growth	-25.78%	-45.88%	-23.15%	-50.80%	96.24%	-50.76%	4.44%	-16.41%	71.99%	-89.88%	109.89%
Net Income Q/Q Growth	-30.73%	-44.65%	-37.67%	-70.64%	230.83%	-30.76%	-45.07%	-25.39%	156.05%	-159.47%	105.28%
EPS Q/Q Growth	-30.77%	-55.56%	-25.00%	-66.67%	200.00%	-33.33%	-50.00%	0.00%	100.00%	-150.00%	100.00%
Operating Cash Flow Q/Q Growth	-4.15%	36.77%	-34.59%	-43.86%	97.83%	-8.19%	-10.87%	-62.84%	106.02%	48.41%	-105.87%
Free Cash Flow Firm Q/Q Growth	102.21%	759.45%	-73.75%	331.00%	20.78%	-69.15%	212.80%	-67.72%	-5.23%	1.34%	-37.94%
Invested Capital Q/Q Growth	0.90%	-17.92%	16.22%	-15.72%	-2.73%	-3.14%	-3.06%	0.58%	-1.57%	-5.42%	0.82%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	73.58%	70.45%	71.02%	70.94%	67.62%	68.73%	72.13%	69.69%	68.64%	66.28%	69.45%
EBITDA Margin	56.85%	48.39%	42.57%	28.39%	39.90%	35.08%	33.11%	28.52%	35.75%	11.38%	23.18%
Operating Margin	50.26%	36.00%	31.25%	17.17%	29.73%	15.36%	19.83%	15.66%	23.51%	3.02%	8.74%
EBIT Margin	48.99%	39.58%	31.47%	16.62%	28.95%	23.38%	18.88%	15.41%	24.07%	-2.22%	8.92%
Profit (Net Income) Margin	34.44%	25.73%	18.42%	5.64%	16.48%	12.62%	7.83%	5.56%	12.43%	-8.74%	0.48%
Tax Burden Percent	80.01%	81.62%	82.99%	77.40%	77.56%	81.75%	74.70%	75.26%	75.26%	81.50%	52.78%
Interest Burden Percent	87.85%	79.66%	70.55%	43.80%	73.41%	66.05%	55.54%	47.95%	68.59%	483.74%	10.18%
Effective Tax Rate	19.99%	18.38%	17.01%	22.60%	22.44%	18.25%	25.30%	24.74%	24.74%	0.00%	47.22%
Return on Invested Capital (ROIC)	22.14%	16.94%	12.42%	5.75%	9.05%	5.34%	5.70%	4.90%	7.45%	0.91%	1.99%
ROIC Less NNEP Spread (ROIC-NNEP)	20.78%	16.11%	11.05%	4.00%	7.13%	5.37%	3.55%	1.86%	3.76%	-7.71%	-1.73%
Return on Net Nonoperating Assets (RNNOA)	25.88%	14.03%	9.84%	2.55%	3.82%	1.75%	1.37%	0.47%	0.74%	-1.14%	-0.22%
Return on Equity (ROE)	48.02%	30.97%	22.26%	8.30%	12.87%	7.09%	7.07%	5.37%	8.19%	-0.23%	1.78%
Cash Return on Invested Capital (CROIC)	0.00%	40.27%	20.27%	33.38%	33.61%	16.10%	32.29%	15.13%	13.37%	14.60%	9.78%
Operating Return on Assets (OROA)	22.73%	17.11%	12.12%	5.25%	8.04%	6.23%	4.81%	3.88%	5.96%	-0.53%	2.13%
Return on Assets (ROA)	15.98%	11.12%	7.10%	1.78%	4.58%	3.37%	2.00%	1.40%	3.08%	-2.10%	0.11%
Return on Common Equity (ROCE)	48.02%	30.97%	22.26%	8.30%	12.87%	7.09%	7.07%	5.37%	8.19%	-0.23%	1.78%
Return on Equity Simple (ROE_SIMPLE)	37.60%	0.00%	25.18%	14.86%	9.65%	0.00%	5.65%	5.56%	4.82%	0.00%	1.39%
Net Operating Profit after Tax (NOPAT)	71	38	30	15	28	14	15	12	21	2.13	4.47
NOPAT Margin	40.22%	29.38%	25.94%	13.29%	23.06%	12.56%	14.82%	11.79%	17.69%	2.12%	4.61%
Net Nonoperating Expense Percent (NNEP)	1.37%	0.84%	1.38%	1.75%	1.91%	-0.03%	2.15%	3.04%	3.68%	8.61%	3.73%
Return On Investment Capital (ROIC_SIMPLE)	-	2.66%	-	-	-	0.94%	-	-	-	0.14%	0.29%
Cost of Revenue to Revenue	26.42%	29.55%	28.98%	29.06%	32.38%	31.27%	27.87%	30.31%	31.36%	33.72%	30.55%
SG&A Expenses to Revenue	17.46%	26.50%	30.69%	44.32%	29.49%	44.01%	40.88%	43.70%	36.07%	52.48%	49.48%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.31%	34.45%	39.76%	53.77%	37.89%	53.36%	52.30%	54.03%	45.13%	63.26%	60.71%
Earnings before Interest and Taxes (EBIT)	86	52	36	18	36	26	19	16	29	-2.23	8.65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	100	63	48	31	49	39	33	30	43	11	22
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.33	4.33	3.45	2.98	1.52	1.97	1.48	1.18	1.77	1.31	0.96
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	8.38	4.80	4.41	4.59	2.67	3.63	2.86	2.33	3.59	2.71	2.01
Price to Earnings (P/E)	22.16	13.86	13.71	20.03	15.74	27.00	26.23	21.24	36.67	58.75	68.95
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.51%	7.22%	7.30%	4.99%	6.35%	3.70%	3.81%	4.71%	2.73%	1.70%	1.45%
Enterprise Value to Invested Capital (EV/IC)	4.84	3.32	2.36	2.47	1.41	1.79	1.41	1.15	1.68	1.29	0.96
Enterprise Value to Revenue (EV/Rev)	8.93	5.29	4.87	5.12	3.15	4.04	3.19	2.66	3.85	2.87	2.17
Enterprise Value to EBITDA (EV/EBITDA)	14.17	8.95	8.94	11.17	7.83	11.03	9.30	7.72	11.58	10.40	8.59
Enterprise Value to EBIT (EV/EBIT)	15.94	10.19	10.50	14.12	10.63	15.99	14.34	12.06	18.65	19.82	17.85
Enterprise Value to NOPAT (EV/NOPAT)	19.92	12.77	13.12	17.67	13.52	21.32	19.61	16.63	26.67	24.95	23.27
Enterprise Value to Operating Cash Flow (EV/OCF)	26.29	14.58	13.28	13.41	7.45	10.43	8.18	7.17	11.71	8.47	9.46
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	7.57	11.49	6.63	3.68	10.68	3.80	7.31	12.11	8.41	9.58
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.89	0.85	0.82	0.81	0.78	0.78	0.76	0.76	0.74	0.74	0.74
Long-Term Debt to Equity	0.88	0.84	0.81	0.80	0.77	0.77	0.76	0.75	0.73	0.74	0.73
Financial Leverage	1.25	0.87	0.89	0.64	0.54	0.33	0.39	0.25	0.20	0.15	0.12
Leverage Ratio	2.67	2.50	2.35	2.24	2.17	2.11	2.09	2.07	2.04	2.04	2.03
Compound Leverage Factor	2.34	1.99	1.66	0.98	1.59	1.40	1.16	0.99	1.40	9.87	0.21
Debt to Total Capital	47.10%	45.91%	44.99%	44.60%	43.88%	43.70%	43.34%	43.07%	42.56%	42.66%	42.50%
Short-Term Debt to Total Capital	0.48%	0.58%	0.46%	0.46%	0.45%	0.45%	0.45%	0.45%	0.44%	0.44%	0.44%
Long-Term Debt to Total Capital	46.62%	45.32%	44.53%	44.14%	43.43%	43.25%	42.89%	42.62%	42.12%	42.21%	42.06%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	52.90%	54.09%	55.01%	55.40%	56.12%	56.30%	56.66%	56.93%	57.44%	57.34%	57.50%
Debt to EBITDA	1.42	1.59	1.92	2.71	3.42	3.90	4.30	4.33	4.52	5.59	6.11
Net Debt to EBITDA	0.88	0.82	0.84	1.15	1.18	1.13	0.97	0.96	0.78	0.55	0.64
Long-Term Debt to EBITDA	1.40	1.57	1.90	2.68	3.39	3.86	4.25	4.28	4.47	5.53	6.05
Debt to NOPAT	2.00	2.27	2.82	4.29	5.91	7.55	9.07	9.33	10.42	13.40	16.56
Net Debt to NOPAT	1.24	1.17	1.24	1.82	2.04	2.18	2.04	2.07	1.81	1.33	1.74
Long-Term Debt to NOPAT	1.98	2.25	2.79	4.24	5.84	7.47	8.97	9.23	10.31	13.26	16.39
Altman Z-Score	5.15	3.44	3.00	2.71	1.98	2.23	1.96	1.79	2.22	1.86	1.69
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.61	9.48	9.68	9.32	10.69	10.92	10.71	9.27	11.84	10.67	10.74
Quick Ratio	3.87	6.70	7.12	7.00	8.57	9.04	8.93	7.67	10.14	9.29	9.22
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	28	239	63	270	326	101	315	102	96	98	61
Operating Cash Flow to CapEx	215,016.00%	13,366.73%	44,942.99%	128,561.90%	48,117.12%	36,055.15%	9,691.13%	15,038.89%	25,542.75%	11,441.94%	-6,077.08%
Free Cash Flow to Firm to Interest Expense	2.65	17.95	4.50	18.40	22.20	6.86	21.70	6.96	6.17	6.56	4.41
Operating Cash Flow to Interest Expense	5.12	5.53	3.46	1.84	3.64	3.34	3.01	1.11	2.14	3.34	-0.21
Operating Cash Flow Less CapEx to Interest Expense	5.12	5.49	3.45	1.84	3.63	3.33	2.98	1.11	2.14	3.31	-0.22
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.43	0.39	0.32	0.28	0.27	0.25	0.25	0.25	0.24	0.24
Accounts Receivable Turnover	9.70	16.19	11.04	8.06	6.58	10.52	12.43	10.40	10.00	15.13	16.95
Inventory Turnover	1.64	1.52	1.38	1.12	1.09	1.16	1.18	1.17	1.32	1.52	1.52
Fixed Asset Turnover	1,042.33	790.87	715.59	661.93	618.67	466.70	391.19	406.23	400.23	356.38	309.48
Accounts Payable Turnover	6.68	11.17	5.86	5.44	5.41	16.61	6.25	7.31	10.63	14.90	6.37
Days Sales Outstanding (DSO)	37.62	22.54	33.05	45.31	55.50	34.70	29.35	35.10	36.51	24.12	21.53
Days Inventory Outstanding (DIO)	222.97	239.90	263.63	327.12	336.13	314.05	308.11	311.39	276.03	239.48	239.53
Days Payable Outstanding (DPO)	54.62	32.67	62.26	67.11	67.51	21.98	58.43	49.96	34.32	24.49	57.26
Cash Conversion Cycle (CCC)	205.97	229.77	234.42	305.32	324.13	326.78	279.04	296.54	278.22	239.11	203.79
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,366	1,121	1,303	1,098	1,068	1,034	1,003	1,009	993	939	947
Invested Capital Turnover	0.55	0.58	0.48	0.43	0.39	0.43	0.38	0.42	0.42	0.43	0.43
Increase / (Decrease) in Invested Capital	43	-200	-33	-256	-298	-87	-300	-89	-75	-95	-56
Enterprise Value (EV)	6,612	3,722	3,074	2,714	1,504	1,852	1,416	1,164	1,669	1,211	912
Market Capitalization	6,199	3,382	2,784	2,434	1,277	1,663	1,269	1,019	1,556	1,147	844
Book Value per Share	$1.15	$1.20	$1.24	$1.25	$1.28	$1.29	$1.30	$1.30	$1.33	$1.32	$1.32
Tangible Book Value per Share	($0.66)	($0.59)	($0.53)	($0.49)	($0.44)	($0.41)	($0.38)	($0.35)	($0.30)	($0.29)	($0.27)
Total Capital	1,406	1,444	1,466	1,476	1,497	1,501	1,510	1,516	1,532	1,525	1,527
Total Debt	662	663	660	658	657	656	654	653	652	650	649
Total Long-Term Debt	656	654	653	652	650	649	648	646	645	644	642
Net Debt	413	340	290	280	228	189	147	145	113	64	68
Capital Expenditures (CapEx)	0.03	0.55	0.11	0.02	0.11	0.14	0.45	0.11	0.13	0.43	0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)	166	153	143	138	122	97	79	83	81	46	64
Debt-free Net Working Capital (DFNWC)	415	476	512	516	551	564	587	591	620	632	645
Net Working Capital (NWC)	409	467	505	509	544	557	580	584	613	625	638
Net Nonoperating Expense (NNE)	10	4.77	8.55	8.36	8.13	-0.07	6.91	6.47	6.27	11	4.01
Net Nonoperating Obligations (NNO)	622	340	496	280	228	189	147	145	113	64	68
Total Depreciation and Amortization (D&A)	14	12	13	13	14	13	14	14	14	14	14
Debt-free, Cash-free Net Working Capital to Revenue	22.44%	21.69%	22.59%	25.97%	25.48%	21.25%	17.82%	18.87%	18.70%	10.85%	15.25%
Debt-free Net Working Capital to Revenue	56.14%	67.53%	81.04%	97.34%	115.48%	123.02%	132.27%	134.80%	142.95%	149.48%	153.31%
Net Working Capital to Revenue	55.22%	66.33%	79.97%	96.07%	114.07%	121.55%	130.75%	133.26%	141.39%	147.88%	151.71%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.09	$0.05	$0.03	$0.01	$0.03	$0.02	$0.01	$0.01	$0.02	($0.01)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	649.10M	649.09M	651.73M	654.35M	654.70M	654.59M	660.82M	661.73M	662.25M	661.98M	664.69M
Adjusted Diluted Earnings per Share	$0.09	$0.04	$0.03	$0.01	$0.03	$0.02	$0.01	$0.01	$0.02	($0.01)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	691.26M	691.01M	683.49M	680.35M	678.76M	677.58M	663.57M	663.55M	666.15M	665.40M	666.46M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	649.18M	651.90M	654.28M	654.70M	654.73M	660.76M	661.76M	661.98M	662.92M	664.62M	665.92M
Normalized Net Operating Profit after Tax (NOPAT)	71	38	30	15	28	14	15	12	21	2.13	4.47
Normalized NOPAT Margin	40.22%	29.38%	25.94%	13.29%	23.06%	12.56%	14.82%	11.79%	17.69%	2.12%	4.61%
Pre Tax Income Margin	43.04%	31.52%	22.20%	7.28%	21.25%	15.44%	10.48%	7.39%	16.51%	-10.72%	0.91%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	8.23	3.89	2.57	1.24	2.43	1.78	1.29	1.10	1.84	-0.15	0.63
NOPAT to Interest Expense	6.76	2.89	2.12	0.99	1.94	0.96	1.01	0.84	1.35	0.14	0.33
EBIT Less CapEx to Interest Expense	8.23	3.85	2.56	1.24	2.43	1.77	1.26	1.09	1.83	-0.18	0.63
NOPAT Less CapEx to Interest Expense	6.76	2.85	2.11	0.99	1.93	0.95	0.98	0.83	1.34	0.11	0.32
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Over the last several years through Q1 2025, Olaplex Holdings, Inc. (NASDAQ: OLPX) has shown a dynamic financial performance with fluctuations in revenues, profitability, and cash flow, reflecting the competitive and evolving nature of the beauty and cosmetics industry.

Positive Financial Trends and Highlights:

Consistent Revenue Generation: Operating revenue has remained robust, with Q1 2025 reporting $96.98 million, close to previous quarters indicating a stable demand for Olaplex’s products despite some recent softness compared to higher revenue quarters in 2022 and earlier in 2023.
Gross Profit Margin Stability: Gross profit in Q1 2025 was $67.36 million, reflecting consistent gross margins around 65%-70% over recent quarters, showing efficient cost management in product manufacturing and pricing power.
Positive Net Income in Q1 2025: The company posted a positive net income of $465,000 in Q1 2025, a rebound from losses in Q4 2024 (-$8.8 million), indicating potential improvements in operational efficiency or cost control measures.
Strong Cash Position: As of Q1 2025, Olaplex held substantial cash and equivalents of $580.89 million, up from $369.34 million in Q1 2023, providing a strong liquidity buffer to support operations and potential investments.
Operating Cash Flow Support: Despite a slight negative cash flow from operations of -$2.9 million in Q1 2025, the company has generally generated positive operating cash flows in prior quarters, e.g., $43.7 million in Q1 2024 and $49 million+ in other quarters, reflecting healthy underlying cash generation over time.
Measured Capital Expenditures and Acquisitions: Investments in property, plant, and equipment remain moderate (around $40,000-$500,000 quarterly), and acquisition spending has been restrained (under $1 million), indicating cautious spending approach.

Neutral Observations:

Amortization Expense Remains High: Amortization expenses consistently around $10-14 million quarterly reflect legacy acquisition costs impacting operating expenses and margins but are non-cash in nature.
Stable Share Count: Weighted average diluted shares outstanding have remained relatively stable around 650-670 million shares, which suggests limited dilution from equity issuances in recent periods.
Modest Fluctuations in Accounts Receivable and Inventory: Changes in working capital (accounts receivable and inventories) have contributed to swings in cash flow but remain typical for the industry.

Negative Financial Trends and Risks:

Operating Expenses Pressure: SG&A expenses have increased in recent quarters (e.g., $47.9 million in Q1 2025 versus $40.4 million in Q1 2024), impacting operating income and requiring monitoring for cost efficiency.
Interest Expense Burden: Interest expense remains substantial (around $13-15 million quarterly) due to significant long-term debt (~$640 million), weighing on net profitability and cash flow.
Net Income Volatility: The company experienced a loss of $8.8 million in Q4 2024 before returning to slight profits in Q1 2025, indicating earnings volatility likely related to macroeconomic or operational factors.
Declining Operating Cash Flow in Q1 2025: Negative operating cash flow in the most recent quarter compared to consistently positive flows in previous periods hints at potential challenges in working capital or business operations.
Long-Term Debt Remains High: Total liabilities stand near $893 million as of Q1 2025, including $642 million in long-term debt, posing leverage risk which may limit flexibility in funding or increase interest costs.

In summary, Olaplex continues to operate with solid revenue and gross profit levels, supported by a strong cash reserve. However, elevated interest expenses, rising operating costs, and recent earnings volatility highlight areas investors should watch closely. The company's ability to stabilize operating cash flow and manage debt will be key to sustaining financial health going forward.

10/03/25 06:41 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Olaplex's Financials

When does Olaplex's financial year end?

According to the most recent income statement we have on file, Olaplex's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Olaplex's net income changed over the last 4 years?

Olaplex's net income appears to be on a downward trend, with a most recent value of $19.52 million in 2024, falling from $39.28 million in 2020. The previous period was $61.59 million in 2023. Check out Olaplex's forecast to explore projected trends and price targets.

What is Olaplex's operating income?

Olaplex's total operating income in 2024 was $66.94 million, based on the following breakdown:

Total Gross Profit: $292.29 million
Total Operating Expenses: $225.35 million

How has Olaplex's revenue changed over the last 4 years?

Over the last 4 years, Olaplex's total revenue changed from $282.25 million in 2020 to $422.67 million in 2024, a change of 49.8%.

How much debt does Olaplex have?

Olaplex's total liabilities were at $893.32 million at the end of 2024, a 0.2% decrease from 2023, and a 11.4% increase since 2020.

How much cash does Olaplex have?

In the past 4 years, Olaplex's cash and equivalents has ranged from $10.96 million in 2020 to $585.97 million in 2024, and is currently $585.97 million as of their latest financial filing in 2024.

How has Olaplex's book value per share changed over the last 4 years?

Over the last 4 years, Olaplex's book value per share changed from 0.84 in 2020 to 1.32 in 2024, a change of 57.9%.

Related Companies

This page (NASDAQ:OLPX) was last updated on 10/3/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Olaplex (OLPX) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Olaplex's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Olaplex (OLPX) Financials

Annual Income Statements for Olaplex

Quarterly Income Statements for Olaplex

Annual Cash Flow Statements for Olaplex

Quarterly Cash Flow Statements for Olaplex

Annual Balance Sheets for Olaplex

Quarterly Balance Sheets for Olaplex

Annual Metrics And Ratios for Olaplex

Quarterly Metrics And Ratios for Olaplex

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Olaplex's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools